All News

This guide provides an overview of stage 2 uterine (endometrial) cancer, including diagnosis, treatment options, and common side effects. A cancer diagnosis is life-changing, and it is natural to feel

October brought developments in the management of blood cancers, from early-stage multiple myeloma to new cellular therapies and novel drug designations.

Dr. Mariano Provencio says many patients still face recurrence after lung cancer surgery and perioperative treatment aims to improve survival.

An opportunity to shine in a day filled with beauty, grief and gratitude, all dolled up in vintage pinup style.

In the ASCENT-07 trial, Trodelvy after endocrine therapy did not improve progression-free survival vs chemotherapy in HR+/HER2- metastatic breast cancer.

In recognition of Pancreatic Cancer Awareness Month, Dr. Suneel Kamath discussed the importance of directing support toward cancers with the unmet needs.

How a beloved childhood toy, a visionary inventor and one grandmother’s journey reveal the quiet strength of survival and the beauty found in every scar.

Kimberly Alexander urges care partners to seek support, prioritize self-care and push for better awareness so families in the Black community aren’t overlooked.

October brought updates in the lung cancer field, ranging from notable trial results to patient perspectives on navigating treatment and survivorship.

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma.

Jeannine Walston, who has contributed to CURE since 2015, was diagnosed with a brain tumor in March 1998.

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape genitourinary cancer care.

More than a quarter of tested patients with non-small cell lung cancer responded to Amtagvi monotherapy.

Specialized sarcoma centers enhance coordinated care for young adults, although travel and financial barriers persist, Dr. Vinayak Venkataraman stated.

This year’s Breast Cancer Awareness Month highlighted FDA approvals, survivorship challenges and advances in breast reconstruction.

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

Long-awaited progress in rectal and gastric cancer research includes a fast track designation and new survival data.

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

A young cancer survivor who underwent external beam radiation therapy and brachytherapy at 14 years old discusses her rare diagnosis, side effects and the nonlink to her Turner syndrome.

The U.S. FDA has granted orphan drug designation to M2T-CD33 for the treatment of patients with acute myeloid leukemia.

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable.

This is an essential guide on stage 2 cervical cancer to support patients in discussing diagnosis, treatment, and care decisions with their oncology team.

Learn how HR-positive/HER2-negative breast cancer is diagnosed, treated by stage and managed for side effects to guide patient-oncologist discussions.

An 11-year survivor of stage 4 breast cancer explains that everyone has a role to play.

CURE spoke with an areola tattoo artist and a patient who has undergone the procedure.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.